AssayIndex
Reports by quarter

Reports submitted in 2026-Q3 · page 10

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.93 % area, n=455. Read the 2026-Q3 state-of-the-index report →

455 records12 pagesmedian on this page 98.73 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042128TB-500JEEPJEEP-2602-V8614Kestrel2026-Q399.933.4394.3Buyer-sourced0PASS
AX-2026-041970TirzepatideAMBAMB-2603-C5112Medutest2026-Q397.513.49105.4Buyer-sourced1FAIL
AX-2026-043596TesamorelinPPGPPG-2608-A6835PeptideMeter2026-Q398.741.83105.1Buyer-sourced1MARGINAL
AX-2026-043355LeuprolideWXTWXT-2604-K2596VendorInvestigate2026-Q398.735.94—Buyer-sourced0PASS
AX-2026-043096RetatrutideKPKP-2607-H5774VendorInvestigate2026-Q396.486.05104.9Buyer-sourced0FAIL
AX-2026-042941CJC-1295 (no DAC)MKMMKM-2603-V3346Nordanalyt2026-Q399.023.62—Buyer-sourced0PASS
AX-2026-042514SemaxHomopeptideHOMO-2605-S5227Janoshik2026-Q399.595.4897.0Buyer-sourced0PASS
AX-2026-042423SemaglutideHomopeptideHOMO-2604-X3806Janoshik2026-Q399.044.8893.2Buyer-sourced0PASS
AX-2026-043537GHRP-2SIGSIG-2603-6031Janoshik2026-Q399.312.16—Buyer-sourced0PASS
AX-2026-043369SemaglutideWXTWXT-2604-C3248Nordanalyt2026-Q397.383.86—Buyer-sourced1MARGINAL
AX-2026-043368SemaglutideWXTWXT-2604-C3248VendorInvestigate2026-Q397.404.25—Buyer-sourced1MARGINAL
AX-2026-043352LeuprolideWXTWXT-2604-K2596Janoshik2026-Q399.115.51—Buyer-sourced0PASS
AX-2026-043351LeuprolideWXTWXT-2604-K2596Kestrel2026-Q398.485.32—Buyer-sourced0FAIL
AX-2026-043186Kisspeptin-10GL BiochemGLBI-2608-N7715Janoshik2026-Q398.563.6096.8Buyer-sourced1MARGINAL
AX-2026-043090RetatrutideKPKP-2607-H5774Janoshik2026-Q396.465.81—Buyer-sourced0FAIL
AX-2026-042940CJC-1295 (no DAC)MKMMKM-2603-V3346VendorInvestigate2026-Q398.613.47—Buyer-sourced0PASS
AX-2026-042225SS-31 (Elamipretide)TFCTFC-2607-R9099Janoshik2026-Q399.614.59—Buyer-sourced0PASS
AX-2026-041981TirzepatideAMBAMB-2603-C5112PeptideMeter2026-Q397.593.5791.3Buyer-sourced0PASS
AX-2026-041791RetatrutideASYASY-{CAT}-2288Janoshik2026-Q398.495.63—Buyer-sourced0PASS
AX-2026-041604CJC-1295 (no DAC)QSCQSC-2606-V7416VendorInvestigate2026-Q397.893.6095.0Buyer-sourced1FAIL
AX-2026-043474CJC-1295 with DACBCHBCH-2607-H5235Janoshik2026-Q397.826.05—Buyer-sourced1MARGINAL
AX-2026-042781CJC-1295 (no DAC)GGPepsGGPE-2606-E1234Janoshik2026-Q397.933.47103.7Buyer-sourced0FAIL
AX-2026-042641SemaglutideSWBSWB-2602-X7905Janoshik2026-Q398.864.4899.1Buyer-sourced0PASS
AX-2026-042597SemaglutideHJHJ-2608-C7002VendorInvestigate2026-Q399.093.90—Buyer-sourced0PASS
AX-2026-042016GHRP-6AMBAMB-2603-S5667PeptideMeter2026-Q399.346.5897.3Buyer-sourced0PASS
AX-2026-041640SemaglutideFGPFGP-2602-M8547PeptideMeter2026-Q399.853.28—Buyer-sourced0PASS
AX-2026-043350LeuprolideWXTWXT-2604-K2596Medutest2026-Q399.015.65101.3Buyer-sourced0PASS
AX-2026-043292LiraglutideCPCCPC-2602-G9942Nordanalyt2026-Q397.524.8089.9Buyer-sourced1MARGINAL
AX-2026-043447BPC-157BCHBCH-2603-G4350Janoshik2026-Q398.564.33—Buyer-sourced1MARGINAL
AX-2026-042596SemaglutideHJHJ-2608-C7002Medutest2026-Q399.643.43100.5Buyer-sourced0PASS
AX-2026-042521SemaxHomopeptideHOMO-2605-S5227Nordanalyt2026-Q399.805.61—Buyer-sourced0PASS
AX-2026-041644SemaglutideFGPFGP-2602-M8547Janoshik2026-Q398.652.0398.2Buyer-sourced0PASS
AX-2026-042500IGF-1 LR3HomopeptideHOMO-2607-P5131Janoshik2026-Q398.976.1786.0Supplier-supplied1MARGINAL
AX-2026-042255TirzepatideTFCTFC-2605-G9870Janoshik2026-Q398.555.80—Buyer-sourced0PASS
AX-2026-041925IGF-1 LR3SinoPepSNP-2606-D4620Janoshik2026-Q397.995.3198.6Buyer-sourced1MARGINAL
AX-2026-041680CJC-1295 with DACTFSTFS-{CAT}-9675Medutest2026-Q399.182.85100.4Buyer-sourced0PASS
AX-2026-041598CJC-1295 (no DAC)QSCQSC-2606-V7416Janoshik2026-Q398.163.76—Buyer-sourced1MARGINAL
AX-2026-042644SemaglutideSWBSWB-2602-X7905PeptideMeter2026-Q398.763.5797.7Buyer-sourced0PASS
AX-2026-042601SemaglutideHJHJ-2608-C7002Janoshik2026-Q399.193.49—Buyer-sourced0PASS
AX-2026-042501IGF-1 LR3HomopeptideHOMO-2607-P5131Janoshik2026-Q398.897.00—Buyer-sourced0PASS